Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
- Resource Type
- Article
- Source
- In
European Journal of Cancer October 2023 192 - Subject
- Language
- ISSN
- 0959-8049